Nucleate, the world’s largest trainee-led biotech accelerator, is now accepting early bird applications for the 2025–2026 cohort of its Activator program. This  opportunity is designed for scientist-entrepreneurs and aspiring contributors who are eager to launch or support transformative life science ventures ranging from novel therapeutics to sustainability technologies.

The Activator program offers access to a global network of peers and over 2,000 industry mentors, including leaders in biotech, venture capital, and pharmaceutical innovation. Participants gain tailored mentorship, strategic guidance, and tools to help advance their ventures. This early application phase allows prospective participants to join the program’s community and begin preparing for the competitive selection process. To apply, interested individuals should create a user profile on the Nucleate Portal and submit their early bird application via the Activator page. The full launch goes live in August.